Publications & Reports

Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts.

Mottram PL, Han W, Murray-Segal L, Pietersz GA, McKenzie IF
University of Melbourne, Department of Surgery, Royal Melbourne Hospital, Victoria, Australia.

Publication

  • Journal: Transplantation Proceedings
  • Published: 01/02/1999
  • Volume: 31
  • Issue: 1-2
  • Pagination: 1414-1415